| Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T … S Lieber, S Reinartz, H Raifer, F Finkernagel, T Dreyer, H Bronger, ... Oncoimmunology 7 (5), e1424672, 2018 | 79 | 2018 |
| Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells H Bronger, A Karge, T Dreyer, D Zech, S Kraeft, S Avril, M Kiechle, ... Oncology Letters 13 (6), 4224-4230, 2017 | 36 | 2017 |
| Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors H Bronger, V Magdolen, P Goettig, T Dreyer Cancer and Metastasis Reviews 38, 417-430, 2019 | 31 | 2019 |
| tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression K Panoutsopoulou, T Dreyer, J Dorn, E Obermayr, S Mahner, T Gorp, ... Cancers 14 (1), 24, 2021 | 29 | 2021 |
| CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer S Seitz, TF Dreyer, C Stange, K Steiger, R Bräuer, L Scheutz, G Multhoff, ... British Journal of Cancer 126 (10), 1470-1480, 2022 | 28 | 2022 |
| Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients W Gong, Y Liu, C Seidl, T Dreyer, E Drecoll, M Kotzsch, H Bronger, J Dorn, ... PloS one 14 (2), e0212968, 2019 | 20 | 2019 |
| Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1 T Kryza, T Khan, S Lovell, BS Harrington, J Yin, S Porazinski, M Pajic, ... Nature chemical biology 17 (7), 776-783, 2021 | 19 | 2021 |
| Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells J Miller, TF Dreyer, AS Bächer, EK Sinner, C Heinrich, A Benge, E Gross, ... Oncotarget 9 (5), 6369, 2018 | 17 | 2018 |
| Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian … X Geng, Y Liu, T Dreyer, H Bronger, E Drecoll, V Magdolen, J Dorn American Journal of Cancer Research 8 (9), 1856, 2018 | 16 | 2018 |
| miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study K Panoutsopoulou, M Avgeris, K Mavridis, T Dreyer, J Dorn, E Obermayr, ... Carcinogenesis 41 (4), 442-451, 2020 | 12 | 2020 |
| The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo TF Dreyer, S Kuhn, C Stange, N Heithorst, D Schilling, J Jelsma, ... Cancer immunology research 9 (7), 779-789, 2021 | 11 | 2021 |
| miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients K Panoutsopoulou, M Avgeris, P Magkou, K Mavridis, T Dreyer, J Dorn, ... International Journal of Cancer 147 (12), 3560-3573, 2020 | 11 | 2020 |
| Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients W Gong, Y Liu, S Preis, X Geng, A Petit-Courty, M Kiechle, ... Molecular Medicine 26, 1-9, 2020 | 11 | 2020 |
| KLK4 induces anti-tumor effects in human xenograft mouse models of orthotopic and metastatic prostate cancer BWC Tse, T Kryza, MC Yeh, Y Dong, KA Sokolowski, C Walpole, T Dreyer, ... Cancers 12 (12), 3501, 2020 | 11 | 2020 |
| Herpes simplex virus alters Alzheimer's disease biomarkers‐A hypothesis paper O Goldhardt, R Freiberger, T Dreyer, L Willner, I Yakushev, M Ortner, ... Alzheimer's & Dementia 19 (5), 2117-2134, 2023 | 7 | 2023 |
| Platelet mitochondrial membrane depolarization reflects disease severity in patients with preeclampsia BF Kraemer, I Hennis, A Karge, AK Kraemer, TF Dreyer, M Kiechle, ... Molecular Medicine 28 (1), 51, 2022 | 7 | 2022 |
| CX3CL1 overexpression prevents the formation of lung metastases in trastuzumab-treated MDA-MB-453-based humanized tumor mice (HTM) AK Wege, TF Dreyer, A Teoman, O Ortmann, G Brockhoff, H Bronger Cancers 13 (10), 2459, 2021 | 7 | 2021 |
| tRNA-derived small RNA 3′ U-tRFValCAC promotes tumour migration and early progression in ovarian cancer K Panoutsopoulou, P Magkou, T Dreyer, J Dorn, E Obermayr, S Mahner, ... European Journal of Cancer 180, 134-145, 2023 | 5 | 2023 |
| Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity G Güner, M Aßfalg, K Zhao, T Dreyer, S Lahiri, Y Lo, BI Slivinschi, A Imhof, ... EMBO Molecular Medicine 14 (10), e16084, 2022 | 5 | 2022 |
| Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer W Gong, C Zhu, Y Liu, A Muckenhuber, H Bronger, A Scorilas, M Kiechle, ... American Journal of Translational Research 13 (3), 1594, 2021 | 5 | 2021 |
